EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitZurückgezogene Publikation

RETRACTED: Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV ‐related hepatocellular carcinoma risk: A system review and meta‐analysis

Xiaofeng Dong, Mengjie Zou, Chunxing Li, Honglin Luo, Shaoliang Zhu iD, Zheng Gong

Environmental Toxicology · 2024

DOI: 10.1002/tox.24286 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Xiaofeng Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Scien…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Genetic Predisposition to Disease, Hepatitis B, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Guangxi Natural Science Fundation, National Natural Science Foundation Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence has suggested a strong association of hepatocellular carcinoma (HCC) susceptibility and Gln223Arg (rs1137101) and Lys109Arg (rs1137100) polymorphisms in leptin receptor (LEPR) genes. To provide a quantitative assessment for such correlation, we reviewed all related systems and conducted meta‐analysis for case and control researches. A literature search of Web of Science, EMBASE, PubMed, Scopus as well as China National Knowledge Infrastructure databases was collected. 95% confidence intervals (95% CIs) together with odds ratios (ORs) were calculated. Five case–control researches consisting of 1323 cases and 1919 control cases were incorporated into meta‐analysis. Researches indicated A‐allelic and AA genotype of rs1137101 were substantially related to boosted susceptibility of hepatitis B virus (HBV)‐related HCC (mutant model, OR = 1.81, 95% CI = 1.36–2.41, p < .001; allelic model, OR = 1.55, 95% CI = 1.32–1.83, p < .001). On the contrary, we observed GG genotype of rs1137101 substantially related to reduced risk of HBV‐related HCC (wild model, OR 0.59, 95%CI = 0.46–0.75, p < .001). We observed AA genotype of rs1137100 relevant to boosted HCC risk (mutant model, OR = 1.51, 95%CI = 1.14–2.01, p = .005) as well as in those with HBV‐related HCCs (homozygous model, OR = 2.12, 95%CI = 1.49–3.02, p < .001; mutant model, OR = 1.67, 95%CI = 1.23–2.26, p = .001). G‐allele and AA genotype of rs1137101 might be in connection with boosted HBV‐related HCC susceptibility, and wild‐type GG genotype might prevent diseases. AA genotype of rs1137100 might also improve HBV‐related HCC susceptibility. Such conclusions ought to be validated by larger and better‐designed researches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularGenetic Predisposition to DiseaseHepatitis BLiver NeoplasmsReceptors, LeptinHumansHepatitis B virusPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

hepatocellular carcinomaleptin receptormeta‐analysispolymorphisms

Substanzen

LEPR protein, humanReceptors, Leptin

Autor:innen und Institutionen

  • Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.
  • Department of Nephrology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.
  • Department of Operating Room, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.
  • Institute of Oncology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.
  • Department of Anesthesiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.

ORCID-Profile: Shaoliang Zhu

Förderung

  • Guangxi Natural Science Fundation
  • National Natural Science Foundation Project of China

Zitieren

APA

Dong, X., Zou, M., Li, C., Luo, H., Zhu, S., & Gong, Z. (2024). RETRACTED: Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV ‐related hepatocellular carcinoma risk: A system review and meta‐analysis. Environmental Toxicology. https://doi.org/10.1002/tox.24286

Vancouver

Dong X, Zou M, Li C, Luo H, Zhu S, Gong Z. RETRACTED: Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV ‐related hepatocellular carcinoma risk: A system review and meta‐analysis. Environmental Toxicology. 2024. doi:10.1002/tox.24286

BibTeX
@article{Dong2024,
  author = {Dong, Xiaofeng and Zou, Mengjie and Li, Chunxing and Luo, Honglin and Zhu, Shaoliang and Gong, Zheng},
  title = {RETRACTED: Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV ‐related hepatocellular carcinoma risk: A system review and meta‐analysis},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.24286}
}
Kostenlos starten →